Clinical guidance for the use of dupilumab in eosinophilic esophagitis
- 12 December 2022
- journal article
- research article
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 130 (3) , 371-378
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Dietary therapy can reverse esophageal subepithelial fibrosis in patients with eosinophilic esophagitis: a historical cohortAllergy, 2012
- Shared Decision Making: A Model for Clinical PracticeJournal of General Internal Medicine, 2012
- Eosinophilic esophagitis: Epithelial mesenchymal transition contributes to esophageal remodeling and reverses with treatmentJournal of Allergy and Clinical Immunology, 2012
- Shared Decision Making — The Pinnacle of Patient-Centered CareNew England Journal of Medicine, 2012
- Subepithelial collagen deposition, profibrogenic cytokine gene expression, and changes after prolonged fluticasone propionate treatment in adult eosinophilic esophagitis: A prospective studyJournal of Allergy and Clinical Immunology, 2011
- Evolving Inflammatory Bowel Disease Treatment Paradigms: Top-Down Versus Step-UpMedical Clinics of North America, 2010
- Resolution of remodeling in eosinophilic esophagitis correlates with epithelial response to topical corticosteroidsAllergy, 2009
- Comparison of Oral Prednisone and Topical Fluticasone in the Treatment of Eosinophilic Esophagitis: A Randomized Trial in ChildrenClinical Gastroenterology and Hepatology, 2008
- Eosinophilic esophagitis attributed to gastroesophageal reflux: Improvement with an amino acid-based formulaGastroenterology, 1995
- Esophageal eosinophilia with dysphagiaDigestive Diseases and Sciences, 1993